Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration
February 29, 2024 07:00 ET
|
Vantage Hemp Co.
Greeley, Colorado, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited plant-based extractor and finished product manufacturer, is proud to...
遊戲《Bellwright》在TGA發佈全新預告片，引發玩家期待
December 08, 2023 08:08 ET
|
Snail, Inc.
洛杉磯, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Snail， Inc.（納斯達克股票代碼：SNAL）（以下簡稱 “蝸牛”或“公司”）是一家全球領先的互動數位娛樂獨立開發商和發行商。 蝸牛與驢子幫工作室（Donkey Crew）在TGA遊戲大獎中展示了即將推出的遊戲《貝爾萊特 Bellwright》的全新預告片。 TGA 遊戲大獎一直致力於展示尖端的遊戲體驗。...
游戏《Bellwright》在TGA发布全新预告片，引发玩家期待
December 08, 2023 08:08 ET
|
Snail, Inc.
洛杉矶, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Snail, Inc.（纳斯达克股票代码：SNAL）（以下简称 “蜗牛”或“公司”）是一家全球领先的互动数字娱乐独立开发商和发行商。蜗牛与驴子帮工作室（Donkey Crew）在TGA游戏大奖中展示了即将推出的游戏《贝尔莱特 Bellwright》的全新预告片。 TGA...
Anticipation Ignites With the Unveiling of a New Bellwright Trailer at the Game Awards
December 08, 2023 08:08 ET
|
Snail, Inc.
LOS ANGELES, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, in...
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
November 07, 2023 08:55 ET
|
PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
Vantage Hemp Co. Concludes Audit with Australia’s Therapeutic Goods Administration
September 21, 2023 07:00 ET
|
Vantage Hemp
Greeley, Colorado, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods...
Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
August 08, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex subsidiary, Clarion Clinics Group Pty Ltd (Clarion) begins accepting registrations of interest in its psychedelic-assisted therapy (PAT) treatments ahead of planned Q3...
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
May 17, 2023 08:15 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement
March 01, 2023 07:30 ET
|
Optimi Health Corp.
Highlights: Signed Purchase Orders with Mind Medicine Australia to ensure that patients with treatment resistant post-traumatic stress disorder (PTSD) have access to medical grade GMP MDMA (using...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
February 03, 2023 00:01 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...